Submission Details
| 510(k) Number | K170901 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 27, 2017 |
| Decision Date | April 13, 2018 |
| Days to Decision | 382 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Statement |
K170901 is an FDA 510(k) clearance for the ALBUMIN, ALKALINE PHOSPHATASE (ALP)-AMP, GLUCOSE-HEXOKINASE, BA400, a Bromcresol Green Dye-binding, Albumin (Class II — Special Controls, product code CIX), submitted by Biosystems S.A. (Barcelona, ES). The FDA issued a Cleared decision on April 13, 2018, 382 days after receiving the submission on March 27, 2017. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1035.
| 510(k) Number | K170901 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 27, 2017 |
| Decision Date | April 13, 2018 |
| Days to Decision | 382 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Statement |
| Product Code | CIX — Bromcresol Green Dye-binding, Albumin |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1035 |